Clinical trial
The PIONEER Initiative: Precision Insights On N-of-1 Effectiveness Research. Tissue Ownership by the Individual With the Return of Actionable Information to the Individual Patient and Physician (Precision Oncology)
NCT03896958 is registered in ClinicalTrials.gov with SpeciCare as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The PIONEER Initiative: Precision Insights On N-of-1 Effectiveness Research. Tissue Ownership by the Individual With the Return of Actionable Information to the Individual Patient and Physician (Precision Oncology)
- Lead sponsor
- SpeciCare
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 21, 2019
- Completion date
- March 12, 2024
- Enrollment
- 1,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adenocarcinoma lung, adrenal cancer, breast cancer, bronchoalveolar cell lung cancer, cancer cords vocal, cancer differentiated poorly, cancer of brain and nervous system, cancer of cervix, cancer of colon, cancer of esophagus, cancer of head and neck, cancer of kidney, cancer of larynx, cancer of liver, cancer of lung, cancer of neck, cancer of pancreas, cancer of prostate, cancer of rectum, cancer of stomach, cancer of vulva, disseminated, cancer skin, cancer unknown primary, cancer, advanced, cancer, all types, cancer, anal, cancer, anaplastic thyroid, cancer, bile duct, cancer, bladder, cancer, metastatic, cancer, other, cancers cell neuroendocrine, cholangiocarcinoma, gist, glioblastoma multiforme, hepatocellular carcinoma, melanoma, oligodendroglioma, renal cell carcinoma, sarcoma, small-cell lung cancer, squamous cell carcinoma, testicular cancer, transitional cell carcinoma, uterine cancer